GT Biopharma, Inc. Common Stock Shares Outstanding

• GT Biopharma, Inc. showed an increase of +1,042.8% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from GT Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), GT Biopharma, Inc.'s Common Stock Shares Outstanding has declined by 82.9%.
• Historical annual values: Fiscal year 2025: 25.53 million shares | Fiscal year 2024: 2.23 million shares | Fiscal year 2023: 1.38 million shares | Fiscal year 2022: 1.09 million shares | Fiscal year 2021: 32.06 million shares | Fiscal year 2020: 5.22 million shares | Fiscal year 2019: 4.10 million shares | Fiscal year 2018: 50.65 million shares | Fiscal year 2017: 50.12 million shares | Fiscal year 2016: 104,218 shares | Fiscal year 2015: 2.40 million shares | Fiscal year 2014: 2.37 million shares | Fiscal year 2013: 573.05 million shares | Fiscal year 2012: 500.57 million shares | Fiscal year 2011: 269.30 million shares | Fiscal year 2010: 149.57 million shares.
• Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: June 24, 2026